BSE Live
Jan 23, 16:01Prev. Close
68.50
Open Price
68.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:42Prev. Close
68.45
Open Price
68.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
66.40 (40)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -1.28 | 2.86 | 2.67 | 1.93 | 2.80 | |
| Diluted EPS (Rs.) | -1.28 | 2.86 | 2.67 | 1.93 | 2.80 | |
| Cash EPS (Rs.) | 1.36 | 5.15 | 4.61 | 3.99 | 4.52 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 34.37 | 35.69 | 33.70 | 31.98 | 30.92 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 34.37 | 35.69 | 33.70 | 31.98 | 30.92 | |
| Dividend / Share(Rs.) | 0.00 | 0.75 | 1.00 | 0.75 | 0.75 | |
| Revenue from Operations/Share (Rs.) | 101.02 | 98.71 | 82.07 | 67.78 | 64.62 | |
| PBDIT/Share (Rs.) | 7.18 | 9.39 | 7.69 | 7.02 | 7.39 | |
| PBIT/Share (Rs.) | 4.50 | 7.65 | 6.17 | 5.66 | 6.26 | |
| PBT/Share (Rs.) | -0.90 | 3.90 | 3.56 | 3.09 | 3.86 | |
| Net Profit/Share (Rs.) | -1.28 | 2.86 | 2.67 | 1.93 | 2.80 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 7.10 | 9.51 | 9.36 | 10.35 | 11.43 | |
| PBIT Margin (%) | 4.45 | 7.74 | 7.52 | 8.34 | 9.69 | |
| PBT Margin (%) | -0.89 | 3.95 | 4.34 | 4.56 | 5.96 | |
| Net Profit Margin (%) | -1.26 | 2.90 | 3.25 | 2.84 | 4.33 | |
| Return on Networth / Equity (%) | -3.72 | 8.02 | 7.93 | 6.03 | 9.05 | |
| Return on Capital Employed (%) | -2.09 | 4.57 | 4.27 | 3.84 | 6.33 | |
| Return on Assets (%) | -1.07 | 2.46 | 2.56 | 2.22 | 3.32 | |
| Total Debt/Equity (X) | 1.51 | 1.26 | 1.28 | 1.06 | 1.11 | |
| Asset Turnover Ratio (%) | 84.69 | 84.84 | 78.62 | 78.21 | 76.61 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.14 | 1.10 | 1.35 | 1.44 | 1.41 | |
| Quick Ratio (X) | 0.67 | 0.67 | 0.76 | 0.81 | 0.81 | |
| Inventory Turnover Ratio (X) | 3.70 | 4.33 | 3.37 | 2.96 | 2.71 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 26.18 | 37.39 | 38.84 | 26.77 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 14.55 | 21.67 | 18.77 | 16.58 | |
| Earnings Retention Ratio (%) | 0.00 | 73.82 | 62.61 | 61.16 | 73.23 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 85.45 | 78.33 | 81.23 | 83.42 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 81.89 | 61.21 | 69.98 | 61.64 | 83.22 | |
| EV/Net Operating Revenue (X) | 0.77 | 0.59 | 0.82 | 0.87 | 1.23 | |
| EV/EBITDA (X) | 10.88 | 6.21 | 8.72 | 8.41 | 10.78 | |
| MarketCap/Net Operating Revenue (X) | 0.27 | 0.15 | 0.32 | 0.38 | 0.78 | |
| Retention Ratios (%) | 0.00 | 73.81 | 62.60 | 61.15 | 73.22 | |
| Price/BV (X) | 0.81 | 0.41 | 0.79 | 0.81 | 1.63 | |
| Price/Net Operating Revenue | 0.27 | 0.15 | 0.32 | 0.38 | 0.78 | |
| Earnings Yield | -0.05 | 0.20 | 0.10 | 0.07 | 0.06 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y